SVR12 is higher than SVR24 in treatment-naïve hepatitis C genotype 1 patients treated with peginterferon plus ribavirin

BACKGROUND: Randomized clinical trials (RCTs) of interventions for the hepatitis C virus have historically used sustained virological response (SVR) at 24 weeks after treatment (SVR24) as the key effect measure. However, recent RCTs investigating the efficacy of new direct acting agents (DAAs) have...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorlund, Kristian, Druyts, Eric, Mills, Edward J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897323/
https://www.ncbi.nlm.nih.gov/pubmed/24474846
http://dx.doi.org/10.2147/CLEP.S53302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897323/
https://www.ncbi.nlm.nih.gov/pubmed/24474846
http://dx.doi.org/10.2147/CLEP.S53302

Ejemplares similares